CoChat

Intraocular inflammation following intravitreal injection of bevacizumab

Bakri, Sophie J., Larson, Theresa A., Edwards, Albert O. · 2008 · Graefe's Archive for Clinical and Experimental Ophthalmology

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Background Injection of drugs into the vitreous can lead to intraocular inflammation through infectious and non-infectious processes. Failure to recognize an eye with anterior chamber and vitreous cell as sterile inflammation can lead to unnecessary treatment for endophthalmitis.Methods Four cases of uveitis following intravitreal bevacizumab (Avastin) for exudative age-related macular degeneration are described followed by review of the literature.Results Four patients presented with uveitis. Two patients presented with pain and red eye associated with iritis and two patients with vitritis, several days following intravitreal injection of bevacizumab. No paracentesis was performed and no corneal epithelial defect was created. Both patients with iritis were presumed to have sterile intraocular inflammation since the anterior chamber cell was much greater than the vitreous cell and resolved with cycloplegic and topical corticosteroid therapy. The third patient presented only with vitreous cell which resolved without therapy. The fourth patient had anterior chamber cell and vitreous cell with clumps, which resolved with topical prednisolone acetate. The inflammation resolved in all cases within 1 to 2 weeks.Conclusion There are few published cases of uveitis following bevacizumab. With its rising use, it is important to be aware of its potential to be associated with intraocular inflammation.

Overview

Integrity signals

Registry

Crossref · 10.1007/s00417-007-0754-7

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Cited by

See all 102

Metadata

Authors
Bakri, S. J., Larson, T. A., & Edwards, A. O.
Affiliations
Mayo Clinic (US)
Corresponding author
Bakri, Sophie J.
Venue
Graefe's Archive for Clinical and Experimental Ophthalmology
Published
2008-01-17
Volume
246
Issue
5
Pages
779-781
ISSN
  • 0721-832X (ISSN-L)
  • 1435-702X
OpenAlex
W2089838877
Cited by
102
References
11
Citations by year
2026: 3 · 2025: 2 · 2024: 1 · 2023: 2 · 2022: 5 · 2021: 6 · 2020: 5 · 2019: 3 · 2018: 2 · 2017: 1 · 2016: 8 · 2015: 4 · 2014: 9 · 2013: 10 · 2012: 6
FWCI
11.47
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Graefe s Archive for Clinical and Experimental Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
  • Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
Keywords
bevacizumab, intravitreal injection, uveitis, intraocular inflammation, sterile inflammation, neovascular age-related macular degeneration, iritis, vitritis, corticosteroid therapy, adverse drug reactions
MeSH terms
Bevacizumab, Aged, Aged, 80 and over, Antibodies, Monoclonal, Female, Glucocorticoids, Humans, Injections, Macular Degeneration, Male, Uveitis, Anterior, Vitreous Body, Angiogenesis Inhibitors, Vascular Endothelial Growth Factor A, Antibodies, Monoclonal, Humanized

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Intraocular inflammation following intravitreal injection of bevacizumab. https://app.cochat.ai/papers/10.1007/s00417-007-0754-7
The paper
Bakri, S. J., Larson, T. A., & Edwards, A. O. (2008). Intraocular inflammation following intravitreal injection of bevacizumab. Graefe's Archive for Clinical and Experimental Ophthalmology. https://doi.org/10.1007/s00417-007-0754-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.